Matt Roache News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesJason butlerAmy liDavid amsellemSravan emanyMatt roacheMike shetzlinePiper sandlerTom mccourtMohit bansalIronwood pharmaceuticals first quarterWells fargoIronwood pharmaceuticals incIronwood pharmaceuticalsCall transcript mayPrivate securities litigation reform act

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGreg martiniMatt roacheIronwood pharmaceuticals incIronwood pharmaceuticals nasdaqIronwood pharmaceuticals

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMichael shetzlineBeth calitriGreg martiniMatt roacheKishorer iyerIronwood pharmaceuticals incIronwood pharmaceuticals nasdaqIronwood pharmaceuticalsExchange commissionPediatric intestine rehabilitationMount sinai hospitalCoordinating principal investigatorShort bowel syndromeAcute graft versus host disease

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results, Achieves 2023 Financial Guidance

BOSTON - Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today reported its fourth quarter and full year 2023 results and recent business performance. In 2023, we made important.

United statesTom mccourtMatt roacheGreg martiniIronwood pharmaceuticalsAbbvie incExchange commissionAmerican society for pediatric gastroenterologyDrug administrationIronwood pharmaceuticals nasdaqIronwood pharmaceuticals incFull yearLancet gastroenterologyAmerican societyPediatric gastroenterologyAnnual meeting

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript February 15, 2024 Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.2. IRWD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]

United statesMike shetzlineAmy liSravan emanyQuality fish oil supplementsGrowing citiesIronwood pharmaceuticalsMike shetzlineTom mccourtPerator instructionsCash flowsFourth quarterMatt roache